Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May 25:8:100411.
doi: 10.1016/j.ssmph.2019.100411. eCollection 2019 Aug.

Reproduction and longevity: A Mendelian randomization study of gonadotropin-releasing hormone and ischemic heart disease

Affiliations

Reproduction and longevity: A Mendelian randomization study of gonadotropin-releasing hormone and ischemic heart disease

C M Schooling et al. SSM Popul Health. .

Abstract

Background: According to well-established evolutionary biology theory there is a trade-off between reproduction and longevity, implying that upregulating the reproductive axis might drive major diseases. We assessed whether the central driver of reproduction gonadotropin-releasing hormone 1 (GnRH1) had a causal effect on the leading cause of global morbidity and mortality, i.e. ischemic heart disease (IHD). As a contrast we similarly examined the role of GnRH2 because it is more a driver of female sexual behavior.

Methods: We applied strong (p-value <5 × 10-6) and independent genetic predictors of GnRH1 and GnRH2 to an extensively genotyped IHD case (n = 76,014) - control (n = 264,785) study and combined the genetic variant specific Wald estimates using inverse variance weighting (IVW) with multiplicative random effects, and as a sensitivity analysis used weighted median, MR-Egger and MR-PRESSO estimates, and repeated the analysis only using genome wide significant genetic predictors.

Findings: GnRH1, predicted by 11 genetic variants, was positively associated with IHD (IVW odds ratio (OR) 1.04 per effect size, 95% confidence interval (CI) 1.01 to 1.08), but GnRH2, predicted by 15 genetic variants, was not (IVW OR 0.98, 95% CI 0.95 to 1.02). Estimates from sensitivity analysis were similar.

Interpretation: GnRH1 is a potential IHD genetic target. Apart from demonstrating a central tenet of evolutionary biology in humans, our study suggests that existing treatments and environmental factors targeting GnRH1, its drivers or consequences could be re-purposed to prevent and treat IHD. Given, the importance of reproduction to the human species, many such exposures likely exist.

Keywords: CVD, cardiovascular disease; Evolutionary biology; GWAS, genome-wide association study; GnRH; GnRH, Gonadotropin-releasing hormone; IHD; IHD, ischemic heart disease; Mendelian randomization; SNP, single nucleotide polymorphism.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Overall IVW (random effects) and SNP-specific estimates for the association of (a) GnRH1 and (b) GnRH2 with IHD.

Similar articles

Cited by

References

    1. Alizon S., Methot P.O. Reconciling Pasteur and Darwin to control infectious diseases. PLoS Biology. 2018;16:e2003815. - PMC - PubMed
    1. Armitage J., Holmes M.V., Preiss D. Cholesteryl ester transfer protein inhibition for preventing cardiovascular events: JACC review topic of the week. Journal of the American College of Cardiology. 2019;73:477–487. - PMC - PubMed
    1. Astle W.J., Elding H., Jiang T., Allen D., Ruklisa D., Mann A.L. The allelic landscape of human blood cell trait variation and links to common complex disease. Cell. 2016;167:1415–1429 e19. - PMC - PubMed
    1. Barker D.J., Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet (London, England) 1986;1:1077–1081. - PubMed
    1. Bateson P., Barker D., Clutton-Brock T., Deb D., D'Udine B., Foley R.A. Developmental plasticity and human health. Nature. 2004;430:419–421. - PubMed